IBDEI0YK ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,15608,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15608,1,3,0)
;;=3^Impaired Fasting Glucose
;;^UTILITY(U,$J,358.3,15608,1,4,0)
;;=4^R73.01
;;^UTILITY(U,$J,358.3,15608,2)
;;=^5019561
;;^UTILITY(U,$J,358.3,15609,0)
;;=R74.8^^61^760^1
;;^UTILITY(U,$J,358.3,15609,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15609,1,3,0)
;;=3^Abnormal Levels of Serum Enzymes
;;^UTILITY(U,$J,358.3,15609,1,4,0)
;;=4^R74.8
;;^UTILITY(U,$J,358.3,15609,2)
;;=^5019566
;;^UTILITY(U,$J,358.3,15610,0)
;;=R03.0^^61^760^27
;;^UTILITY(U,$J,358.3,15610,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15610,1,3,0)
;;=3^Elevated BP Reading w/o Diagnosis of HTN
;;^UTILITY(U,$J,358.3,15610,1,4,0)
;;=4^R03.0
;;^UTILITY(U,$J,358.3,15610,2)
;;=^5019171
;;^UTILITY(U,$J,358.3,15611,0)
;;=Z91.19^^61^760^53
;;^UTILITY(U,$J,358.3,15611,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15611,1,3,0)
;;=3^Noncompliance w/ Medical Treatment/Regimen
;;^UTILITY(U,$J,358.3,15611,1,4,0)
;;=4^Z91.19
;;^UTILITY(U,$J,358.3,15611,2)
;;=^5063618
;;^UTILITY(U,$J,358.3,15612,0)
;;=E66.01^^61^760^54
;;^UTILITY(U,$J,358.3,15612,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15612,1,3,0)
;;=3^Obesity,Morbid
;;^UTILITY(U,$J,358.3,15612,1,4,0)
;;=4^E66.01
;;^UTILITY(U,$J,358.3,15612,2)
;;=^5002826
;;^UTILITY(U,$J,358.3,15613,0)
;;=F43.11^^61^760^61
;;^UTILITY(U,$J,358.3,15613,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15613,1,3,0)
;;=3^PTSD,Acute
;;^UTILITY(U,$J,358.3,15613,1,4,0)
;;=4^F43.11
;;^UTILITY(U,$J,358.3,15613,2)
;;=^5003571
;;^UTILITY(U,$J,358.3,15614,0)
;;=F43.12^^61^760^62
;;^UTILITY(U,$J,358.3,15614,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15614,1,3,0)
;;=3^PTSD,Chronic
;;^UTILITY(U,$J,358.3,15614,1,4,0)
;;=4^F43.12
;;^UTILITY(U,$J,358.3,15614,2)
;;=^5003572
;;^UTILITY(U,$J,358.3,15615,0)
;;=I25.119^^61^760^5
;;^UTILITY(U,$J,358.3,15615,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15615,1,3,0)
;;=3^Athscl Hrt Dis of Native Cor Art w/ Ang Pctrs,Unspec
;;^UTILITY(U,$J,358.3,15615,1,4,0)
;;=4^I25.119
;;^UTILITY(U,$J,358.3,15615,2)
;;=^5007111
;;^UTILITY(U,$J,358.3,15616,0)
;;=I25.10^^61^760^6
;;^UTILITY(U,$J,358.3,15616,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15616,1,3,0)
;;=3^Athscl Hrt Dis of Native Cor Art w/o Ang Pctrs
;;^UTILITY(U,$J,358.3,15616,1,4,0)
;;=4^I25.10
;;^UTILITY(U,$J,358.3,15616,2)
;;=^5007107
;;^UTILITY(U,$J,358.3,15617,0)
;;=F17.219^^61^760^51
;;^UTILITY(U,$J,358.3,15617,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15617,1,3,0)
;;=3^Nicotine Dependence,Cigarettes
;;^UTILITY(U,$J,358.3,15617,1,4,0)
;;=4^F17.219
;;^UTILITY(U,$J,358.3,15617,2)
;;=^5003369
;;^UTILITY(U,$J,358.3,15618,0)
;;=Z51.5^^61^760^64
;;^UTILITY(U,$J,358.3,15618,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15618,1,3,0)
;;=3^Palliative Care Encounter
;;^UTILITY(U,$J,358.3,15618,1,4,0)
;;=4^Z51.5
;;^UTILITY(U,$J,358.3,15618,2)
;;=^5063063
;;^UTILITY(U,$J,358.3,15619,0)
;;=Z23.^^61^760^28
;;^UTILITY(U,$J,358.3,15619,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15619,1,3,0)
;;=3^Encounter for Immunization(s)
;;^UTILITY(U,$J,358.3,15619,1,4,0)
;;=4^Z23.
;;^UTILITY(U,$J,358.3,15619,2)
;;=^5062795
;;^UTILITY(U,$J,358.3,15620,0)
;;=E11.65^^61^760^20
;;^UTILITY(U,$J,358.3,15620,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15620,1,3,0)
;;=3^DM Type 2 Uncontrolled w/ Hyperglycemia
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0YK 3777 printed Oct 16, 2024@17:59:06 Page 2
IBDEI0YK ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,15608,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,15608,1,3,0)
+4 ;;=3^Impaired Fasting Glucose
+5 ;;^UTILITY(U,$J,358.3,15608,1,4,0)
+6 ;;=4^R73.01
+7 ;;^UTILITY(U,$J,358.3,15608,2)
+8 ;;=^5019561
+9 ;;^UTILITY(U,$J,358.3,15609,0)
+10 ;;=R74.8^^61^760^1
+11 ;;^UTILITY(U,$J,358.3,15609,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,15609,1,3,0)
+14 ;;=3^Abnormal Levels of Serum Enzymes
+15 ;;^UTILITY(U,$J,358.3,15609,1,4,0)
+16 ;;=4^R74.8
+17 ;;^UTILITY(U,$J,358.3,15609,2)
+18 ;;=^5019566
+19 ;;^UTILITY(U,$J,358.3,15610,0)
+20 ;;=R03.0^^61^760^27
+21 ;;^UTILITY(U,$J,358.3,15610,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,15610,1,3,0)
+24 ;;=3^Elevated BP Reading w/o Diagnosis of HTN
+25 ;;^UTILITY(U,$J,358.3,15610,1,4,0)
+26 ;;=4^R03.0
+27 ;;^UTILITY(U,$J,358.3,15610,2)
+28 ;;=^5019171
+29 ;;^UTILITY(U,$J,358.3,15611,0)
+30 ;;=Z91.19^^61^760^53
+31 ;;^UTILITY(U,$J,358.3,15611,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,15611,1,3,0)
+34 ;;=3^Noncompliance w/ Medical Treatment/Regimen
+35 ;;^UTILITY(U,$J,358.3,15611,1,4,0)
+36 ;;=4^Z91.19
+37 ;;^UTILITY(U,$J,358.3,15611,2)
+38 ;;=^5063618
+39 ;;^UTILITY(U,$J,358.3,15612,0)
+40 ;;=E66.01^^61^760^54
+41 ;;^UTILITY(U,$J,358.3,15612,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,15612,1,3,0)
+44 ;;=3^Obesity,Morbid
+45 ;;^UTILITY(U,$J,358.3,15612,1,4,0)
+46 ;;=4^E66.01
+47 ;;^UTILITY(U,$J,358.3,15612,2)
+48 ;;=^5002826
+49 ;;^UTILITY(U,$J,358.3,15613,0)
+50 ;;=F43.11^^61^760^61
+51 ;;^UTILITY(U,$J,358.3,15613,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,15613,1,3,0)
+54 ;;=3^PTSD,Acute
+55 ;;^UTILITY(U,$J,358.3,15613,1,4,0)
+56 ;;=4^F43.11
+57 ;;^UTILITY(U,$J,358.3,15613,2)
+58 ;;=^5003571
+59 ;;^UTILITY(U,$J,358.3,15614,0)
+60 ;;=F43.12^^61^760^62
+61 ;;^UTILITY(U,$J,358.3,15614,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,15614,1,3,0)
+64 ;;=3^PTSD,Chronic
+65 ;;^UTILITY(U,$J,358.3,15614,1,4,0)
+66 ;;=4^F43.12
+67 ;;^UTILITY(U,$J,358.3,15614,2)
+68 ;;=^5003572
+69 ;;^UTILITY(U,$J,358.3,15615,0)
+70 ;;=I25.119^^61^760^5
+71 ;;^UTILITY(U,$J,358.3,15615,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,15615,1,3,0)
+74 ;;=3^Athscl Hrt Dis of Native Cor Art w/ Ang Pctrs,Unspec
+75 ;;^UTILITY(U,$J,358.3,15615,1,4,0)
+76 ;;=4^I25.119
+77 ;;^UTILITY(U,$J,358.3,15615,2)
+78 ;;=^5007111
+79 ;;^UTILITY(U,$J,358.3,15616,0)
+80 ;;=I25.10^^61^760^6
+81 ;;^UTILITY(U,$J,358.3,15616,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,15616,1,3,0)
+84 ;;=3^Athscl Hrt Dis of Native Cor Art w/o Ang Pctrs
+85 ;;^UTILITY(U,$J,358.3,15616,1,4,0)
+86 ;;=4^I25.10
+87 ;;^UTILITY(U,$J,358.3,15616,2)
+88 ;;=^5007107
+89 ;;^UTILITY(U,$J,358.3,15617,0)
+90 ;;=F17.219^^61^760^51
+91 ;;^UTILITY(U,$J,358.3,15617,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,15617,1,3,0)
+94 ;;=3^Nicotine Dependence,Cigarettes
+95 ;;^UTILITY(U,$J,358.3,15617,1,4,0)
+96 ;;=4^F17.219
+97 ;;^UTILITY(U,$J,358.3,15617,2)
+98 ;;=^5003369
+99 ;;^UTILITY(U,$J,358.3,15618,0)
+100 ;;=Z51.5^^61^760^64
+101 ;;^UTILITY(U,$J,358.3,15618,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,15618,1,3,0)
+104 ;;=3^Palliative Care Encounter
+105 ;;^UTILITY(U,$J,358.3,15618,1,4,0)
+106 ;;=4^Z51.5
+107 ;;^UTILITY(U,$J,358.3,15618,2)
+108 ;;=^5063063
+109 ;;^UTILITY(U,$J,358.3,15619,0)
+110 ;;=Z23.^^61^760^28
+111 ;;^UTILITY(U,$J,358.3,15619,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,15619,1,3,0)
+114 ;;=3^Encounter for Immunization(s)
+115 ;;^UTILITY(U,$J,358.3,15619,1,4,0)
+116 ;;=4^Z23.
+117 ;;^UTILITY(U,$J,358.3,15619,2)
+118 ;;=^5062795
+119 ;;^UTILITY(U,$J,358.3,15620,0)
+120 ;;=E11.65^^61^760^20
+121 ;;^UTILITY(U,$J,358.3,15620,1,0)
+122 ;;=^358.31IA^4^2
+123 ;;^UTILITY(U,$J,358.3,15620,1,3,0)
+124 ;;=3^DM Type 2 Uncontrolled w/ Hyperglycemia
